Back to BlackRock, Inc. BlackRock, Inc.

MNPRMNPR
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in MONOPAR THERAPEUTICS INC

BlackRock, Inc. holds 348,819 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $32.3M as of 2026-Q2. The position was increased (+10.2% shares). MNPR represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$32.3M

Current Shares

348,819

Total Value Change

+$32.1M

Total Shares Change

+340,718

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
348,819
+10.2%
$32.3M0.0%$92.59
32
2026-Q1
Increased
316,567
+24.2%
$17.3M0.0%$51.88
34
2025-Q4
Increased
254,857
+25.1%
$16.6M0.0%$65.07
35
2025-Q3
Decreased
203,751
-0.7%
$16.6M0.0%$75.90
0
2025-Q2
Increased
205,169
+1318.5%
$7.3M0.0%$33.60
44
2025-Q1
Increased
14,464
+78.5%
$526,6350.0%$40.33
25
2024-Q4
New
8,101
-
$178,2220.0%$23.85
35

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used